Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/12915429
Conclusion of this study
Despite plausible mechanisms of action, guggulipid did not appear to improve levels of serum cholesterol over the short term in this population of adults with hypercholesterolemia, and might in fact raise levels of LDL-C. Guggulipid also appeared to cause a dermatologic hypersensitivity reaction in some patients.
Supplements analyzed in this study
|
Health conditions analyzed in this study
No health conditions information for this study.Functions related to this study
|
||
|
Body systems related to this study
 Cardiovascular System |
